K. Sakai

发表

Efficacy of switching from premix analog insulin twice daily injection to insulin glargine once daily injection with sitagliptin

K. Kawanishi, K. Igawa, Junko Suzuki, 2015, Diabetology International.

A phase II study to explore biomarkers for the use of mFOLFOX6/XELOX plus bevacizumab as a first-line chemotherapy in patients with metastatic colorectal cancer (WJOG7612GTR)

I. Hyodo, K. Muro, N. Boku, 2022, ESMO open.

Phase II study of NK105, a paclitaxel-incorporating micellar nanoparticle as second-line treatment for advanced or recurrent gastric cancer.

T. Yoshikawa, Ken Kato, Y. Matsumura, 2010 .